BioCentury | Jun 11, 2019
Distillery Therapeutics

Inhibiting FANCM-TOP3A-RMI1 interaction for osteosarcoma, Lesch-Nyhan syndrome

...Victoria, Australia email: adeans@svi.edu.au CONTACT: Hilda A. Pickett, University of Sydney, Sydney, Australia email: hpickett@cmri.org.au Claire Quang St. Vincent's Institute of Medical Research University...
BioCentury | Oct 18, 2018
Distillery Techniques

Assays and screens; biomarkers

...doi:10.1073/pnas.1809208115 CONTACT: Stuart I. Mannering, St. Vincent’s Institute of Medical Research, Fitzroy, Australia email: smannering@svi.edu.au Claire Quang St. Vincent's Institute of Medical Research Diabetes C-peptide proinsulin...
BioCentury | Feb 4, 2016
Distillery Therapeutics

Therapeutics: v-myc myelocytomatosis viral oncogene homolog (MYC; c-Myc); ATM interactor (ATMIN); dynein light chain LC8-type 1 (DYNLL1)

...Wong, D. et al. Cell Rep.; published online Jan. 28, 2016 doi:10.1016/j.celrep.2016.01.012 CONTACT: Jörg Heierhorst, St. Vincent's Institute of Medical Research...
BioCentury | Nov 5, 2012
Company News

Servier, Florey Institute of Neuroscience and Mental Health, Monash University, St. Vincent's Institute of Medical Research neurology news

...Florey Institute of Neuroscience and Mental Health , Victoria, Australia Monash University , Victoria, Australia St. Vincent's Institute of Medical Research...
Items per page:
1 - 4 of 4
BioCentury | Jun 11, 2019
Distillery Therapeutics

Inhibiting FANCM-TOP3A-RMI1 interaction for osteosarcoma, Lesch-Nyhan syndrome

...Victoria, Australia email: adeans@svi.edu.au CONTACT: Hilda A. Pickett, University of Sydney, Sydney, Australia email: hpickett@cmri.org.au Claire Quang St. Vincent's Institute of Medical Research University...
BioCentury | Oct 18, 2018
Distillery Techniques

Assays and screens; biomarkers

...doi:10.1073/pnas.1809208115 CONTACT: Stuart I. Mannering, St. Vincent’s Institute of Medical Research, Fitzroy, Australia email: smannering@svi.edu.au Claire Quang St. Vincent's Institute of Medical Research Diabetes C-peptide proinsulin...
BioCentury | Feb 4, 2016
Distillery Therapeutics

Therapeutics: v-myc myelocytomatosis viral oncogene homolog (MYC; c-Myc); ATM interactor (ATMIN); dynein light chain LC8-type 1 (DYNLL1)

...Wong, D. et al. Cell Rep.; published online Jan. 28, 2016 doi:10.1016/j.celrep.2016.01.012 CONTACT: Jörg Heierhorst, St. Vincent's Institute of Medical Research...
BioCentury | Nov 5, 2012
Company News

Servier, Florey Institute of Neuroscience and Mental Health, Monash University, St. Vincent's Institute of Medical Research neurology news

...Florey Institute of Neuroscience and Mental Health , Victoria, Australia Monash University , Victoria, Australia St. Vincent's Institute of Medical Research...
Items per page:
1 - 4 of 4